K171401

Substantially Equivalent

ELITech Clinical Systems BILIRUBIN TOTAL 4+1, ELITech Clinical Systems BILIRUBIN DIRECT 4+1

Applicant: Elitechgroup
Product code: CIG
Advisory panel: Clinical Chemistry
Date received: 2017-05-12
Decision date: 2017-07-11
Decision: Substantially Equivalent
Clearance type: Traditional
Location: Sees, FR

Download summary PDF View on FDA.gov ↗

Data sourced from openFDA. This site is unofficial and independent of the FDA.